Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma

Surein Arulananda; Megan O'Brien; Marco Evangelista; Tiffany J Harris; Nikita S Steinohrt; Laura J Jenkins; Marzena Walkiewicz; Robert J J O'Donoghue; Ashleigh R Poh; Bibhusal Thapa; David S Williams; Trishe Leong; John M Mariadason; Xia Li; Jonathan Cebon; Erinna F Lee; Thomas John; W Douglas Fairlie

doi:10.1038/s41420-020-00388-7

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma

Cell Death Discov. 2021 Jun 15;7(1):146. doi: 10.1038/s41420-020-00388-7.

Authors

Surein Arulananda^{1

2

3}, Megan O'Brien¹, Marco Evangelista¹, Tiffany J Harris¹, Nikita S Steinohrt¹, Laura J Jenkins^{1

2}, Marzena Walkiewicz¹, Robert J J O'Donoghue^{1

4}, Ashleigh R Poh^{1

2}, Bibhusal Thapa¹, David S Williams^{1

2

5

6}, Trishe Leong^{3

5

6}, John M Mariadason^{1

2}, Xia Li⁷, Jonathan Cebon^{1

2

3}, Erinna F Lee^{8

9

10}, Thomas John^{11

12

13

14}, W Douglas Fairlie^{15

16

17}

Affiliations

¹ Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.
² School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.
³ Department of Medical Oncology, Austin Health, Heidelberg, VIC, Australia.
⁴ Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, VIC, Australia.
⁵ Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia.
⁶ Department of Pathology, Austin Health, Heidelberg, VIC, Australia.
⁷ Department of Mathematics and Statistics, La Trobe University, Bundoora, VIC, Australia.
⁸ Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. Erinna.Lee@latrobe.edu.au.
⁹ School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia. Erinna.Lee@latrobe.edu.au.
¹⁰ Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia. Erinna.Lee@latrobe.edu.au.
¹¹ Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. tom.john@petermac.org.
¹² School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia. tom.john@petermac.org.
¹³ Department of Medical Oncology, Austin Health, Heidelberg, VIC, Australia. tom.john@petermac.org.
¹⁴ Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. tom.john@petermac.org.
¹⁵ Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. doug.fairlie@onjcri.org.au.
¹⁶ School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia. doug.fairlie@onjcri.org.au.
¹⁷ Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia. doug.fairlie@onjcri.org.au.

No abstract available

Publication types

Published Erratum